Sam L. Barker, Director at Cyclacel Pharmaceuticals, Inc. (CYCC), sold 12 shares at $3.57 ($43) on 2021-11-30, disclosed to the SEC on 2021-12-02.
Open-market sale of $43 CYCC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LXRX | BUY | 2017-09-18 | $13K | — | Filing → |
| CYCC | BUY | 2014-11-20 | $9K | — | Filing → |
| CADX | BUY | 2011-05-11 | $63K | — | Filing → |